rs939336

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005688.4(ABCC5):ā€‹c.1782T>Cā€‹(p.Cys594=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.571 in 1,611,950 control chromosomes in the GnomAD database, including 267,442 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.62 ( 30499 hom., cov: 32)
Exomes š‘“: 0.57 ( 236943 hom. )

Consequence

ABCC5
NM_005688.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.150
Variant links:
Genes affected
ABCC5 (HGNC:56): (ATP binding cassette subfamily C member 5) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein functions in the cellular export of its substrate, cyclic nucleotides. This export contributes to the degradation of phosphodiesterases and possibly an elimination pathway for cyclic nucleotides. Studies show that this protein provides resistance to thiopurine anticancer drugs, 6-mercatopurine and thioguanine, and the anti-HIV drug 9-(2-phosphonylmethoxyethyl)adenine. This protein may be involved in resistance to thiopurines in acute lymphoblastic leukemia and antiretroviral nucleoside analogs in HIV-infected patients. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 3-183967746-A-G is Benign according to our data. Variant chr3-183967746-A-G is described in ClinVar as [Benign]. Clinvar id is 1252281.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.15 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.84 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ABCC5NM_005688.4 linkuse as main transcriptc.1782T>C p.Cys594= synonymous_variant 12/30 ENST00000334444.11 NP_005679.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ABCC5ENST00000334444.11 linkuse as main transcriptc.1782T>C p.Cys594= synonymous_variant 12/301 NM_005688.4 ENSP00000333926 P1O15440-1
ABCC5ENST00000265586.10 linkuse as main transcriptc.1782T>C p.Cys594= synonymous_variant 12/295 ENSP00000265586 O15440-5
ABCC5ENST00000476402.1 linkuse as main transcriptn.290T>C non_coding_transcript_exon_variant 2/22
ABCC5ENST00000437205.5 linkuse as main transcriptc.*475T>C 3_prime_UTR_variant, NMD_transcript_variant 12/305 ENSP00000403510

Frequencies

GnomAD3 genomes
AF:
0.624
AC:
94823
AN:
151996
Hom.:
30455
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.766
Gnomad AMI
AF:
0.457
Gnomad AMR
AF:
0.583
Gnomad ASJ
AF:
0.551
Gnomad EAS
AF:
0.860
Gnomad SAS
AF:
0.563
Gnomad FIN
AF:
0.501
Gnomad MID
AF:
0.592
Gnomad NFE
AF:
0.558
Gnomad OTH
AF:
0.631
GnomAD3 exomes
AF:
0.582
AC:
145318
AN:
249500
Hom.:
43691
AF XY:
0.576
AC XY:
77995
AN XY:
135370
show subpopulations
Gnomad AFR exome
AF:
0.780
Gnomad AMR exome
AF:
0.524
Gnomad ASJ exome
AF:
0.550
Gnomad EAS exome
AF:
0.859
Gnomad SAS exome
AF:
0.552
Gnomad FIN exome
AF:
0.502
Gnomad NFE exome
AF:
0.556
Gnomad OTH exome
AF:
0.582
GnomAD4 exome
AF:
0.566
AC:
825669
AN:
1459836
Hom.:
236943
Cov.:
40
AF XY:
0.564
AC XY:
409949
AN XY:
726342
show subpopulations
Gnomad4 AFR exome
AF:
0.774
Gnomad4 AMR exome
AF:
0.531
Gnomad4 ASJ exome
AF:
0.552
Gnomad4 EAS exome
AF:
0.864
Gnomad4 SAS exome
AF:
0.546
Gnomad4 FIN exome
AF:
0.510
Gnomad4 NFE exome
AF:
0.554
Gnomad4 OTH exome
AF:
0.577
GnomAD4 genome
AF:
0.624
AC:
94919
AN:
152114
Hom.:
30499
Cov.:
32
AF XY:
0.618
AC XY:
45943
AN XY:
74334
show subpopulations
Gnomad4 AFR
AF:
0.766
Gnomad4 AMR
AF:
0.583
Gnomad4 ASJ
AF:
0.551
Gnomad4 EAS
AF:
0.861
Gnomad4 SAS
AF:
0.561
Gnomad4 FIN
AF:
0.501
Gnomad4 NFE
AF:
0.558
Gnomad4 OTH
AF:
0.637
Alfa
AF:
0.573
Hom.:
59637
Bravo
AF:
0.636
Asia WGS
AF:
0.730
AC:
2539
AN:
3478
EpiCase
AF:
0.564
EpiControl
AF:
0.577

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxDec 27, 2019- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
3.2
DANN
Benign
0.52

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs939336; hg19: chr3-183685534; COSMIC: COSV55588306; API